Priming of strong, broad, and long-lived HIV type 1 p55(gag)-specific CD8(+) cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques

Paliard, Xavier and Liu, Yuan and Wagner, Ralf and Wolf, Hans and Baenziger, Juerg and Walker, Christopher M. (2000) Priming of strong, broad, and long-lived HIV type 1 p55(gag)-specific CD8(+) cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS RESEARCH AND HUMAN RETROVIRUSES, 16 (3). pp. 273-282. ISSN 0889-2229

Full text not available from this repository.

Abstract

Despite advances in the clinical management of HIV infection, using combinations of antiretroviral pharmaceuticals, a safe and efficacious vaccine is needed to Limit the AIDS pandemic. It is now thought that an effective HIV-1 vaccine should prime both cross-neutralizing antibodies and long-lasting cytotoxic CD8(+) T lymphocytes (CTLs) recognizing multiple codominant HIV-1 epitopes, To that end, many novel vaccine strategies have been tested, However, only a few of these strategies, beside those relying on live-attenuated viruses, are able to prime strong CTL responses in nonhuman primates and humans. In this study, three rhesus macaques were immunized with HIV-1 p55(gag) virus-like particles (VLPs) in the absence of adjuvant to assess the potential of such a vaccine to prime CTL responses. After intramuscular injection of p55(gag) VLP, all three animals mounted CTL responses against HIV-1 p55(gag). Notably, these CTLs primed by vaccination recognized naturally processed peptides and were long lived (>8.5 months) both in the peripheral blood and draining lymph node. Furthermore, these CTLs mere directed against multiple HIV-1 p55(gag) epitopes. This indicated that immunization with p55(gag) VLP primes strong MHC class I-restricted, CD8(+) cell-mediated immune responses and suggested that HIV-1 p55(gag) VLPs should be a reasonable vaccine candidate, when combined with strategies priming cross-neutralizing antibodies.

Item Type: Article
Uncontrolled Keywords: HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; LYMPHOCYTE RESPONSES; IN-VIVO; HETEROLOGOUS PROTECTION; ATTENUATED SIV; CTL RESPONSES; VIRAL LOAD; INFECTION; INDUCTION;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Dr. Gernot Deinzer
Date Deposited: 07 Jun 2022 06:34
Last Modified: 07 Jun 2022 06:34
URI: https://pred.uni-regensburg.de/id/eprint/42825

Actions (login required)

View Item View Item